Reuters logo
4 months ago
BRIEF-Starlake Bioscience cancels acquisition plan for up to 35 pct stake in Guangzhou pharma
March 28, 2017 / 10:10 AM / 4 months ago

BRIEF-Starlake Bioscience cancels acquisition plan for up to 35 pct stake in Guangzhou pharma

1 Min Read

March 28(Reuters) - Starlake Bioscience :

* Says it canceled plan to buy up to 35 percent stake in a Guangzhou-based pharma company

Source text in Chinese: goo.gl/Nkyi5H

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below